{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T13:45:52Z","timestamp":1746107152744,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>There have been no reports on the effectiveness of the administration of antithrombin III (AT III) for post-transplant portal vein thrombosis (PVT). We herein report a case of post-transplant PVT that was resolved by AT III treatment after living donor liver transplantation (LDLT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>The patient was a 57-year-old man who had been diagnosed with decompensate liver cirrhosis by hepatitis C virus infection. He presented with repeated hepatic coma and refractory ascites. Computed tomography (CT) revealed PVT of Yerdel classification grade II before LDLT. He underwent ABO-identical LDLT using a right lobe graft. A liver function test revealed elevated liver enzyme levels on post-operative day (POD) 14. The CT examination on POD 15 revealed PVT in the left side of the main portal vein at the side of left gastric vein ligation. AT III treatment from POD 15 to POD 24 was performed. Magnetic resonance imaging revealed that the PVT had decreased 10% on POD 27. Furthermore, AT III treatment from POD 28 to POD 32 was performed. The CT examination demonstrated the disappearance of PVT on POD 69 and thereafter, he had no recurrence of PVT on 10 post-operative month (POM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The present case suggests that the administration of AT III is safe and suitable for the treatment of post-transplant PVT.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40792-020-00920-y","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T10:02:46Z","timestamp":1593770566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antithrombin III treatment for portal vein thrombosis after living donor liver transplantation: a case report"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2728-2648","authenticated-orcid":false,"given":"Yuta","family":"Hirata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Omameuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Katano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunaru","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Sata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"920_CR1","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/hep.1840160515","volume":"16","author":"T Nonami","year":"1992","unstructured":"Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology. 1992;16:1195\u20138.","journal-title":"Hepatology"},{"key":"920_CR2","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1111\/j.1600-6143.2008.02400.x","volume":"8","author":"A Rana","year":"2008","unstructured":"Rana A, Hardy MA, Halazun KJ, Woodlamd DC, Ratner LE, Samstein B, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008;8:2537\u201346.","journal-title":"Am J Transplant"},{"key":"920_CR3","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1111\/hepr.12934","volume":"48","author":"H Hidaka","year":"2018","unstructured":"Hidaka H, Kokubu S, Sato T, Katsushima S, Izumi N, Igura T, et al. NPB-06 study group. Antithrombin III for portal vein thrombosis in patients with liver disease: a randomized, double-blind, controlled trial. Hepatol Res. 2018;48:E107\u201316.","journal-title":"Hepatol Res"},{"key":"920_CR4","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1016\/j.transproceed.2008.10.104","volume":"41","author":"H Imai","year":"2009","unstructured":"Imai H, Egawa H, Kajiwara M, Nakajima A, Ogura Y, Hatano E, et al. Resolution of preoperative portal vein thrombosis after administration of antithrombin III in living donor liver transplantation: case report. Transplant Proc. 2009;41:3931\u20133.","journal-title":"Transplant Proc"},{"key":"920_CR5","first-page":"1008","volume":"55","author":"Y Kishi","year":"2008","unstructured":"Kishi Y, Sugawara Y, Matsui Y, Akamatsu N, Makuuchi M. Late onset portal vein thrombosis and its risk factors. Hepatogastroenterology. 2008;55:1008\u20139.","journal-title":"Hepatogastroenterology"},{"key":"920_CR6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1399-0012.2007.00728.x","volume":"21","author":"L Llado","year":"2007","unstructured":"Llado L, Fabregat J, Castellote J, Ramos E, Torras J, Jorba R, et al. Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality. Clin Transplant. 2007;21:716\u201321.","journal-title":"Clin Transplant"},{"key":"920_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/archsurg.1996.01430200050009","volume":"131","author":"P Seu","year":"1996","unstructured":"Seu P, Shackleton CR, Shaked A, Imagawa DK, Olthoff KM, Rudich SR, et al. Improved results of liver transplantation in patients with portal vein thrombosis. Arch Surg. 1996;131:840\u20134.","journal-title":"Arch Surg"},{"key":"920_CR8","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1016\/j.transproceed.2005.09.120","volume":"37","author":"R Charco","year":"2005","unstructured":"Charco R, Fuster J, Fondevila C, Ferrer J, Mans E, Garcia-Valdecasas JC. Portal vein thrombosis in liver transplantation. Transplant Proc. 2005;37:3904\u20135.","journal-title":"Transplant Proc"},{"key":"920_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","volume":"10","author":"MG Delgado","year":"2012","unstructured":"Delgado MG, Seijo S, Yepes I, Achecar L, Catalina MV, Garcia-Criado A, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol hepatol. 2012;10:776\u201383.","journal-title":"Clin Gastroenterol hepatol"},{"key":"920_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","volume":"143","author":"E Villa","year":"2012","unstructured":"Villa E, Camma C, Marietta M, Luong M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation on patients with advanced cirrhosis. Gatroenterology. 2012;143:1253\u201360.","journal-title":"Gatroenterology"},{"key":"920_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/hepr.12400","volume":"45","author":"N Naeshiro","year":"2015","unstructured":"Naeshiro N, Aikata H, Hyogo H, Kan H, Fujino H, Kobayashi T, et al. Efficacy and safety of anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2015;45:656\u201362.","journal-title":"Hepatol Res"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-020-00920-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-020-00920-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-020-00920-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T04:20:30Z","timestamp":1723177230000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-020-00920-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["920"],"URL":"https:\/\/doi.org\/10.1186\/s40792-020-00920-y","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Consent for publication was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}